2024-09-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.1% |
3.65% |
2024-09-11 |
NVAX
Novavax, Inc.
|
Buy |
9.92% |
1.81% |
2024-09-11 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
13.26% |
2.3% |
2024-09-12 |
RGNX
REGENXBIO Inc.
|
Buy |
12.14% |
1.89% |
2024-09-12 |
AGEN
Agenus Inc.
|
Buy |
12.05% |
5.06% |
2024-09-13 |
LLY
Eli Lilly and Company
|
Buy |
11.11% |
-3.08% |
2024-09-13 |
SRNE
Sorrento Therapeutics, Inc.
|
Buy |
12.14% |
-8.33% |
2024-09-13 |
IRTC
iRhythm Technologies, Inc.
|
Buy |
12.53% |
-6.66% |
2024-09-16 |
TDOC
Teladoc Health, Inc.
|
Buy |
15.12% |
12.61% |
2024-09-16 |
MRSN
Mersana Therapeutics, Inc.
|
Buy |
12.98% |
-3.32% |
2024-09-16 |
CARA
Cara Therapeutics, Inc.
|
Sell |
-5.67% |
4.98% |
2024-09-11 |
SIGA
SIGA Technologies, Inc.
|
Sell |
-6.16% |
-4.93% |
2024-09-12 |
BGNE
BeiGene, Ltd.
|
Sell |
-5.93% |
-0.63% |
2024-09-13 |
CHRS
Coherus BioSciences, Inc.
|
Sell |
-5.66% |
0.95% |
2024-09-17 |
KIDS
OrthoPediatrics Corp.
|
Sell |
-6.59% |
0% |
2024-09-18 |
The percentage of cash held in the portfolio is:
8.65%
New Assets Added
Assets Removed
None
Assets Rebalanced
Asset |
Action |
Weight |
ESPR |
Buy |
1.41% |
RGNX |
Buy |
1.46% |
SRNE |
Buy |
1.63% |
2024-09-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.16% |
1.66% |
2024-09-11 |
NVAX
Novavax, Inc.
|
Buy |
10.38% |
3.94% |
2024-09-11 |
RGNX
REGENXBIO Inc.
|
Buy |
10.78% |
0.24% |
2024-09-12 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
10.88% |
1.15% |
2024-09-12 |
SRNE
Sorrento Therapeutics, Inc.
|
Buy |
10.39% |
-11.67% |
2024-09-13 |
AGEN
Agenus Inc.
|
Buy |
12.06% |
2.53% |
2024-09-13 |
LLY
Eli Lilly and Company
|
Buy |
11.62% |
-1.23% |
2024-09-13 |
IRTC
iRhythm Technologies, Inc.
|
Buy |
13.25% |
-3.8% |
2024-09-16 |
TDOC
Teladoc Health, Inc.
|
Buy |
13.89% |
0.87% |
2024-09-16 |
MRSN
Mersana Therapeutics, Inc.
|
Buy |
12.86% |
-6.64% |
2024-09-16 |
CARA
Cara Therapeutics, Inc.
|
Sell |
-5.83% |
4.63% |
2024-09-11 |
SIGA
SIGA Technologies, Inc.
|
Sell |
-6.41% |
-6.39% |
2024-09-12 |
BGNE
BeiGene, Ltd.
|
Sell |
-6.04% |
-0.09% |
2024-09-13 |
CHRS
Coherus BioSciences, Inc.
|
Sell |
-5.86% |
0% |
2024-09-17 |
The percentage of cash held in the portfolio is:
7.88%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
9.82% |
-0.33% |
2024-09-11 |
NVAX
Novavax, Inc.
|
Buy |
10.56% |
7.17% |
2024-09-11 |
RGNX
REGENXBIO Inc.
|
Buy |
10.72% |
1.02% |
2024-09-12 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
11.65% |
9.77% |
2024-09-12 |
SRNE
Sorrento Therapeutics, Inc.
|
Buy |
8.7% |
-25% |
2024-09-13 |
AGEN
Agenus Inc.
|
Buy |
12.25% |
5.56% |
2024-09-13 |
LLY
Eli Lilly and Company
|
Buy |
11.46% |
-1.21% |
2024-09-13 |
IRTC
iRhythm Technologies, Inc.
|
Buy |
13.59% |
0% |
2024-09-16 |
TDOC
Teladoc Health, Inc.
|
Buy |
13.59% |
0% |
2024-09-16 |
MRSN
Mersana Therapeutics, Inc.
|
Buy |
13.59% |
0% |
2024-09-16 |
CARA
Cara Therapeutics, Inc.
|
Sell |
-5.65% |
6.41% |
2024-09-11 |
SIGA
SIGA Technologies, Inc.
|
Sell |
-6.25% |
-5.19% |
2024-09-12 |
BGNE
BeiGene, Ltd.
|
Sell |
-6.03% |
-1.13% |
2024-09-13 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.02% |
1.33% |
2024-09-11 |
NVAX
Novavax, Inc.
|
Buy |
9.28% |
-6.14% |
2024-09-11 |
RGNX
REGENXBIO Inc.
|
Buy |
10.2% |
-4.17% |
2024-09-12 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
10.71% |
0.57% |
2024-09-12 |
SRNE
Sorrento Therapeutics, Inc.
|
Buy |
11.64% |
0% |
2024-09-13 |
AGEN
Agenus Inc.
|
Buy |
11.64% |
0% |
2024-09-13 |
LLY
Eli Lilly and Company
|
Buy |
11.64% |
0% |
2024-09-13 |
CARA
Cara Therapeutics, Inc.
|
Sell |
-5.82% |
3.91% |
2024-09-11 |
SIGA
SIGA Technologies, Inc.
|
Sell |
-6.25% |
-4.79% |
2024-09-12 |
BGNE
BeiGene, Ltd.
|
Sell |
-5.98% |
0% |
2024-09-13 |
The percentage of cash held in the portfolio is:
42.9%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.12% |
2.99% |
2024-09-11 |
NVAX
Novavax, Inc.
|
Buy |
9.51% |
-3.23% |
2024-09-11 |
RGNX
REGENXBIO Inc.
|
Buy |
10.58% |
0% |
2024-09-12 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
10.58% |
0% |
2024-09-12 |
CARA
Cara Therapeutics, Inc.
|
Sell |
-6.3% |
-4.63% |
2024-09-11 |
SIGA
SIGA Technologies, Inc.
|
Sell |
-5.93% |
0% |
2024-09-12 |
The percentage of cash held in the portfolio is:
71.42%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
9.8% |
0% |
2024-09-11 |
NVAX
Novavax, Inc.
|
Buy |
9.8% |
0% |
2024-09-11 |
CARA
Cara Therapeutics, Inc.
|
Sell |
-6% |
0% |
2024-09-11 |
The percentage of cash held in the portfolio is:
86.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-30 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
KIDS |
Sell
All
|
12.95% |
Assets Rebalanced
None
2024-08-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
KIDS
OrthoPediatrics Corp.
|
Buy |
12.4% |
15.23% |
2024-08-16 |
The percentage of cash held in the portfolio is:
87.6%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
OFIX |
Buy
All
|
-7.98% |
Assets Rebalanced
None
2024-08-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
KIDS
OrthoPediatrics Corp.
|
Buy |
11.76% |
8.86% |
2024-08-16 |
OFIX
Orthofix Medical Inc.
|
Sell |
-6.14% |
-3.87% |
2024-08-13 |
The percentage of cash held in the portfolio is:
94.38%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ICUI |
Sell
All
|
4.94% |
VCYT |
Sell
All
|
3.64% |
INGN |
Sell
All
|
4.71% |
CPRX |
Sell
All
|
13.33% |
Assets Rebalanced
None
2024-08-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ICUI
ICU Medical, Inc.
|
Buy |
11.08% |
3.93% |
2024-08-09 |
VCYT
Veracyte, Inc.
|
Buy |
10.49% |
5.54% |
2024-08-09 |
INGN
Inogen, Inc.
|
Buy |
10.21% |
6.86% |
2024-08-09 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Buy |
11.37% |
11.86% |
2024-08-09 |
KIDS
OrthoPediatrics Corp.
|
Buy |
12.21% |
13.75% |
2024-08-16 |
OFIX
Orthofix Medical Inc.
|
Sell |
-6.08% |
-3.62% |
2024-08-13 |
The percentage of cash held in the portfolio is:
50.73%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MD |
Sell
All
|
12.88% |
EXEL |
Sell
All
|
-0.72% |
Assets Rebalanced
None
2024-08-21 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MD
Pediatrix Medical Group, Inc.
|
Buy |
11.9% |
11.63% |
2024-08-08 |
EXEL
Exelixis, Inc.
|
Buy |
11.17% |
-0.15% |
2024-08-08 |
ICUI
ICU Medical, Inc.
|
Buy |
11.05% |
2.58% |
2024-08-09 |
VCYT
Veracyte, Inc.
|
Buy |
10.62% |
5.74% |
2024-08-09 |
INGN
Inogen, Inc.
|
Buy |
10.39% |
7.54% |
2024-08-09 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Buy |
11.61% |
13.06% |
2024-08-09 |
KIDS
OrthoPediatrics Corp.
|
Buy |
11.18% |
3.08% |
2024-08-16 |
OFIX
Orthofix Medical Inc.
|
Sell |
-6.05% |
-2% |
2024-08-13 |
The percentage of cash held in the portfolio is:
28.13%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
THC |
Sell
All
|
6.2% |
GKOS |
Sell
All
|
6.82% |
AXSM |
Sell
All
|
3.09% |
Assets Rebalanced
None
2024-08-20 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
THC
Tenet Healthcare Corporation
|
Buy |
11.16% |
6.86% |
2024-08-07 |
GKOS
Glaukos Corporation
|
Buy |
11.16% |
8.37% |
2024-08-07 |
AXSM
Axsome Therapeutics, Inc.
|
Buy |
11.16% |
5.57% |
2024-08-07 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
11.86% |
11.94% |
2024-08-08 |
EXEL
Exelixis, Inc.
|
Buy |
11.16% |
0.26% |
2024-08-08 |
ICUI
ICU Medical, Inc.
|
Buy |
11.03% |
2.98% |
2024-08-09 |
VCYT
Veracyte, Inc.
|
Buy |
10.78% |
7.91% |
2024-08-09 |
INGN
Inogen, Inc.
|
Buy |
10.45% |
8.83% |
2024-08-09 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Buy |
11.16% |
9.23% |
2024-08-09 |
KIDS
OrthoPediatrics Corp.
|
Buy |
11.16% |
3.44% |
2024-08-16 |
OFIX
Orthofix Medical Inc.
|
Sell |
-6.04% |
-2.43% |
2024-08-13 |
The percentage of cash held in the portfolio is:
-5.01%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CVS |
Buy
All
|
-1.71% |
Assets Rebalanced
Asset |
Action |
Weight |
INGN |
Sell |
-1.54% |
EXEL |
Sell |
-1.16% |
THC |
Sell |
-1.29% |
KIDS |
Sell |
-1.32% |
GKOS |
Sell |
-1.41% |
CPRX |
Sell |
-2.25% |
AXSM |
Sell |
-2.49% |
2024-08-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
THC
Tenet Healthcare Corporation
|
Buy |
12.6% |
7.18% |
2024-08-07 |
GKOS
Glaukos Corporation
|
Buy |
12.78% |
9.17% |
2024-08-07 |
AXSM
Axsome Therapeutics, Inc.
|
Buy |
13.15% |
0.76% |
2024-08-07 |
EXEL
Exelixis, Inc.
|
Buy |
12.32% |
-0.64% |
2024-08-08 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
11.57% |
8.1% |
2024-08-08 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Buy |
13.46% |
8.58% |
2024-08-09 |
INGN
Inogen, Inc.
|
Buy |
12.26% |
10.11% |
2024-08-09 |
ICUI
ICU Medical, Inc.
|
Buy |
11.32% |
4.68% |
2024-08-09 |
VCYT
Veracyte, Inc.
|
Buy |
11.05% |
9.61% |
2024-08-09 |
KIDS
OrthoPediatrics Corp.
|
Buy |
12.05% |
-1.01% |
2024-08-16 |
CVS
CVS Health Corporation
|
Sell |
-7.53% |
-0.93% |
2024-08-06 |
OFIX
Orthofix Medical Inc.
|
Sell |
-6% |
-0.62% |
2024-08-13 |
The percentage of cash held in the portfolio is:
-9.04%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VREX |
Buy
All
|
2.93% |
CDXS |
Buy
All
|
11.82% |
Assets Rebalanced
Asset |
Action |
Weight |
ICUI |
Sell |
-1.65% |
VCYT |
Sell |
-2.53% |
INGN |
Sell |
-1.39% |
AXSM |
Buy |
1.69% |
2024-08-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
THC
Tenet Healthcare Corporation
|
Buy |
12.55% |
6.15% |
2024-08-07 |
GKOS
Glaukos Corporation
|
Buy |
12.62% |
7.22% |
2024-08-07 |
AXSM
Axsome Therapeutics, Inc.
|
Buy |
11.45% |
0.11% |
2024-08-07 |
EXEL
Exelixis, Inc.
|
Buy |
12.37% |
-0.79% |
2024-08-08 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
11.51% |
6.96% |
2024-08-08 |
VCYT
Veracyte, Inc.
|
Buy |
13.58% |
8.98% |
2024-08-09 |
INGN
Inogen, Inc.
|
Buy |
13.47% |
8.05% |
2024-08-09 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Buy |
13.56% |
8.8% |
2024-08-09 |
ICUI
ICU Medical, Inc.
|
Buy |
13.02% |
4.47% |
2024-08-09 |
KIDS
OrthoPediatrics Corp.
|
Buy |
12.24% |
0% |
2024-08-16 |
VREX
Varex Imaging Corporation
|
Sell |
-5.81% |
3.08% |
2024-08-05 |
CDXS
Codexis, Inc.
|
Sell |
-5.1% |
14.85% |
2024-08-05 |
CVS
CVS Health Corporation
|
Sell |
-7.47% |
0.43% |
2024-08-06 |
OFIX
Orthofix Medical Inc.
|
Sell |
-6.1% |
-1.75% |
2024-08-13 |
The percentage of cash held in the portfolio is:
-1.9%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
RCM |
Sell
All
|
-1.13% |
BLUE |
Buy
All
|
34.26% |
Assets Rebalanced
None
2024-08-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
12.86% |
-1.27% |
2024-08-02 |
THC
Tenet Healthcare Corporation
|
Buy |
12.8% |
3.64% |
2024-08-07 |
GKOS
Glaukos Corporation
|
Buy |
12.8% |
4.07% |
2024-08-07 |
AXSM
Axsome Therapeutics, Inc.
|
Buy |
11.87% |
-0.7% |
2024-08-07 |
EXEL
Exelixis, Inc.
|
Buy |
13.23% |
1.55% |
2024-08-08 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
11.82% |
5.19% |
2024-08-08 |
VCYT
Veracyte, Inc.
|
Buy |
13% |
-0.17% |
2024-08-09 |
INGN
Inogen, Inc.
|
Buy |
13.15% |
1.03% |
2024-08-09 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Buy |
13.73% |
5.46% |
2024-08-09 |
ICUI
ICU Medical, Inc.
|
Buy |
12.74% |
-2.17% |
2024-08-09 |
BLUE
bluebird bio, Inc.
|
Sell |
-5.63% |
9.26% |
2024-08-02 |
VREX
Varex Imaging Corporation
|
Sell |
-5.2% |
16.95% |
2024-08-05 |
CDXS
Codexis, Inc.
|
Sell |
-5.35% |
14.55% |
2024-08-05 |
CVS
CVS Health Corporation
|
Sell |
-7.57% |
3.46% |
2024-08-06 |
OFIX
Orthofix Medical Inc.
|
Sell |
-6.26% |
0% |
2024-08-13 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
RVNC |
Buy
All
|
-95.85% |
Assets Rebalanced
Asset |
Action |
Weight |
MD |
Sell |
-1.88% |
AXSM |
Sell |
-2.45% |
THC |
Sell |
-2.14% |
GKOS |
Sell |
-2.2% |
RCM |
Buy |
2.86% |
2024-08-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
9.6% |
-1.13% |
2024-08-02 |
GKOS
Glaukos Corporation
|
Buy |
14.26% |
3.2% |
2024-08-07 |
THC
Tenet Healthcare Corporation
|
Buy |
14.19% |
2.7% |
2024-08-07 |
AXSM
Axsome Therapeutics, Inc.
|
Buy |
13.74% |
-0.61% |
2024-08-07 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
12.75% |
2.08% |
2024-08-08 |
EXEL
Exelixis, Inc.
|
Buy |
12.79% |
2.45% |
2024-08-08 |
ICUI
ICU Medical, Inc.
|
Buy |
12.49% |
0% |
2024-08-09 |
INGN
Inogen, Inc.
|
Buy |
12.49% |
0% |
2024-08-09 |
VCYT
Veracyte, Inc.
|
Buy |
12.49% |
0% |
2024-08-09 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Buy |
12.49% |
0% |
2024-08-09 |
RVNC
Revance Therapeutics, Inc.
|
Sell |
-5.21% |
12.46% |
2024-08-02 |
BLUE
bluebird bio, Inc.
|
Sell |
-5.56% |
6.48% |
2024-08-02 |
VREX
Varex Imaging Corporation
|
Sell |
-5.27% |
12.25% |
2024-08-05 |
CDXS
Codexis, Inc.
|
Sell |
-5.73% |
4.55% |
2024-08-05 |
CVS
CVS Health Corporation
|
Sell |
-7.52% |
-0.07% |
2024-08-06 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
9.67% |
-1.2% |
2024-08-02 |
GKOS
Glaukos Corporation
|
Buy |
13.83% |
-0.69% |
2024-08-07 |
THC
Tenet Healthcare Corporation
|
Buy |
13.86% |
-0.46% |
2024-08-07 |
AXSM
Axsome Therapeutics, Inc.
|
Buy |
13.65% |
-1.95% |
2024-08-07 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
12.58% |
0% |
2024-08-08 |
EXEL
Exelixis, Inc.
|
Buy |
12.58% |
0% |
2024-08-08 |
RVNC
Revance Therapeutics, Inc.
|
Sell |
-5.01% |
16.32% |
2024-08-02 |
BLUE
bluebird bio, Inc.
|
Sell |
-5.21% |
12.96% |
2024-08-02 |
VREX
Varex Imaging Corporation
|
Sell |
-5.33% |
11.79% |
2024-08-05 |
CDXS
Codexis, Inc.
|
Sell |
-5.53% |
8.48% |
2024-08-05 |
CVS
CVS Health Corporation
|
Sell |
-7.4% |
2.32% |
2024-08-06 |
The percentage of cash held in the portfolio is:
52.32%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
TNDM |
Sell
All
|
-11.11% |
CERS |
Sell
All
|
-11.06% |
Assets Rebalanced
None
2024-08-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
9.57% |
-1.27% |
2024-08-02 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
11.46% |
4.13% |
2024-08-05 |
CERS
Cerus Corporation
|
Buy |
10.26% |
-6.81% |
2024-08-05 |
GKOS
Glaukos Corporation
|
Buy |
13.79% |
0% |
2024-08-07 |
THC
Tenet Healthcare Corporation
|
Buy |
13.79% |
0% |
2024-08-07 |
AXSM
Axsome Therapeutics, Inc.
|
Buy |
13.79% |
0% |
2024-08-07 |
RVNC
Revance Therapeutics, Inc.
|
Sell |
-5.42% |
8.61% |
2024-08-02 |
BLUE
bluebird bio, Inc.
|
Sell |
-5.6% |
5.56% |
2024-08-02 |
VREX
Varex Imaging Corporation
|
Sell |
-5.37% |
10.25% |
2024-08-05 |
CDXS
Codexis, Inc.
|
Sell |
-5.84% |
2.42% |
2024-08-05 |
CVS
CVS Health Corporation
|
Sell |
-7.57% |
-0.92% |
2024-08-06 |
The percentage of cash held in the portfolio is:
57.15%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
9.62% |
-1.27% |
2024-08-02 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
10.84% |
-2.11% |
2024-08-05 |
CERS
Cerus Corporation
|
Buy |
10.46% |
-5.53% |
2024-08-05 |
RVNC
Revance Therapeutics, Inc.
|
Sell |
-5.42% |
9.2% |
2024-08-02 |
BLUE
bluebird bio, Inc.
|
Sell |
-5.47% |
8.33% |
2024-08-02 |
VREX
Varex Imaging Corporation
|
Sell |
-5.71% |
5.08% |
2024-08-05 |
CDXS
Codexis, Inc.
|
Sell |
-5.86% |
2.73% |
2024-08-05 |
CVS
CVS Health Corporation
|
Sell |
-7.54% |
0% |
2024-08-06 |
The percentage of cash held in the portfolio is:
99.08%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
9.74% |
-0.57% |
2024-08-02 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
11.12% |
0% |
2024-08-05 |
CERS
Cerus Corporation
|
Buy |
11.12% |
0% |
2024-08-05 |
RVNC
Revance Therapeutics, Inc.
|
Sell |
-5.69% |
5.04% |
2024-08-02 |
BLUE
bluebird bio, Inc.
|
Sell |
-6.16% |
-2.78% |
2024-08-02 |
VREX
Varex Imaging Corporation
|
Sell |
-6.05% |
0% |
2024-08-05 |
CDXS
Codexis, Inc.
|
Sell |
-6.05% |
0% |
2024-08-05 |
The percentage of cash held in the portfolio is:
91.97%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
9.8% |
0% |
2024-08-02 |
RVNC
Revance Therapeutics, Inc.
|
Sell |
-6% |
0% |
2024-08-02 |
BLUE
bluebird bio, Inc.
|
Sell |
-6% |
0% |
2024-08-02 |
The percentage of cash held in the portfolio is:
102.2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-24 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
SNDX |
Sell
All
|
3.15% |
SAGE |
Sell
All
|
14.04% |
ATXS |
Sell
All
|
14.43% |
TVTX |
Sell
All
|
3.06% |
BLUE |
Sell
All
|
24% |
Assets Rebalanced
None
2024-07-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SNDX
Syndax Pharmaceuticals, Inc.
|
Buy |
10.84% |
3.63% |
2024-07-10 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
11.67% |
11.6% |
2024-07-10 |
ATXS
Astria Therapeutics, Inc.
|
Buy |
10.96% |
15.51% |
2024-07-10 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9% |
1.69% |
2024-07-10 |
BLUE
bluebird bio, Inc.
|
Buy |
9.86% |
14% |
2024-07-10 |
The percentage of cash held in the portfolio is:
47.68%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CERS |
Sell
All
|
18.37% |
AVXL |
Sell
All
|
31.04% |
Assets Rebalanced
None
2024-07-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CERS
Cerus Corporation
|
Buy |
10.15% |
12.24% |
2024-07-09 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
10.08% |
21.51% |
2024-07-09 |
SNDX
Syndax Pharmaceuticals, Inc.
|
Buy |
11.03% |
2.26% |
2024-07-10 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
11.56% |
7.15% |
2024-07-10 |
ATXS
Astria Therapeutics, Inc.
|
Buy |
10.76% |
9.91% |
2024-07-10 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.43% |
3.27% |
2024-07-10 |
BLUE
bluebird bio, Inc.
|
Buy |
9.37% |
5% |
2024-07-10 |
The percentage of cash held in the portfolio is:
27.63%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MCRB |
Sell
All
|
25.9% |
MODV |
Buy
All
|
7.31% |
Assets Rebalanced
None
2024-07-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CERS
Cerus Corporation
|
Buy |
10.05% |
12.76% |
2024-07-09 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
10.35% |
26.61% |
2024-07-09 |
MCRB
Seres Therapeutics, Inc.
|
Buy |
9.14% |
29.5% |
2024-07-09 |
SNDX
Syndax Pharmaceuticals, Inc.
|
Buy |
10.95% |
2.88% |
2024-07-10 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
11.29% |
6.1% |
2024-07-10 |
ATXS
Astria Therapeutics, Inc.
|
Buy |
10.47% |
8.44% |
2024-07-10 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.31% |
3.37% |
2024-07-10 |
BLUE
bluebird bio, Inc.
|
Buy |
10.12% |
15% |
2024-07-10 |
MODV
ModivCare Inc.
|
Sell |
-4.5% |
6.4% |
2024-07-08 |
The percentage of cash held in the portfolio is:
22.82%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
NKTR |
Sell
All
|
4.65% |
Assets Rebalanced
None
2024-07-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NKTR
Nektar Therapeutics
|
Buy |
10.26% |
12.4% |
2024-07-08 |
CERS
Cerus Corporation
|
Buy |
10.26% |
20.41% |
2024-07-09 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
10.26% |
31.26% |
2024-07-09 |
MCRB
Seres Therapeutics, Inc.
|
Buy |
10.26% |
52.11% |
2024-07-09 |
SNDX
Syndax Pharmaceuticals, Inc.
|
Buy |
10.67% |
4.96% |
2024-07-10 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
10.77% |
5.93% |
2024-07-10 |
ATXS
Astria Therapeutics, Inc.
|
Buy |
10.26% |
11.19% |
2024-07-10 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.34% |
8.43% |
2024-07-10 |
BLUE
bluebird bio, Inc.
|
Buy |
10.26% |
22% |
2024-07-10 |
MODV
ModivCare Inc.
|
Sell |
-4.6% |
-0.04% |
2024-07-08 |
The percentage of cash held in the portfolio is:
12.26%
New Assets Added
None
Assets Removed
None
Assets Rebalanced
Asset |
Action |
Weight |
TVTX |
Sell |
-1.69% |
ATXS |
Sell |
-1.05% |
NKTR |
Sell |
-1.7% |
BLUE |
Sell |
-2.15% |
CERS |
Sell |
-3.11% |
AVXL |
Sell |
-4.31% |
MCRB |
Sell |
-6.62% |
2024-07-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NKTR
Nektar Therapeutics
|
Buy |
12.14% |
13.95% |
2024-07-08 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
14.37% |
29.27% |
2024-07-09 |
CERS
Cerus Corporation
|
Buy |
13.55% |
21.94% |
2024-07-09 |
MCRB
Seres Therapeutics, Inc.
|
Buy |
14.51% |
30.52% |
2024-07-09 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
10.96% |
7.69% |
2024-07-10 |
ATXS
Astria Therapeutics, Inc.
|
Buy |
11.83% |
16.19% |
2024-07-10 |
SNDX
Syndax Pharmaceuticals, Inc.
|
Buy |
11.19% |
9.92% |
2024-07-10 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
10.79% |
6.02% |
2024-07-10 |
BLUE
bluebird bio, Inc.
|
Buy |
13.74% |
35% |
2024-07-10 |
MODV
ModivCare Inc.
|
Sell |
-4.7% |
-2.16% |
2024-07-08 |
The percentage of cash held in the portfolio is:
-8.37%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
DNLI |
Buy
All
|
-10.12% |
AGEN |
Buy
All
|
-21.82% |
Assets Rebalanced
None
2024-07-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NKTR
Nektar Therapeutics
|
Buy |
11.85% |
8.53% |
2024-07-08 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
14.73% |
29.27% |
2024-07-09 |
CERS
Cerus Corporation
|
Buy |
13.08% |
14.8% |
2024-07-09 |
MCRB
Seres Therapeutics, Inc.
|
Buy |
13.93% |
22.3% |
2024-07-09 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
10.79% |
3.37% |
2024-07-10 |
ATXS
Astria Therapeutics, Inc.
|
Buy |
12.12% |
16.09% |
2024-07-10 |
SNDX
Syndax Pharmaceuticals, Inc.
|
Buy |
11.27% |
8.02% |
2024-07-10 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
10.74% |
2.88% |
2024-07-10 |
BLUE
bluebird bio, Inc.
|
Buy |
13.78% |
32% |
2024-07-10 |
DNLI
Denali Therapeutics Inc.
|
Sell |
-5.77% |
-7.31% |
2024-07-03 |
AGEN
Agenus Inc.
|
Sell |
-5.52% |
-7.36% |
2024-07-04 |
MODV
ModivCare Inc.
|
Sell |
-4.58% |
2.87% |
2024-07-08 |
The percentage of cash held in the portfolio is:
3.6%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
NUTX |
Buy
All
|
-37.1% |
Assets Rebalanced
None
2024-07-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NKTR
Nektar Therapeutics
|
Buy |
12.4% |
5.43% |
2024-07-08 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
13.45% |
9.53% |
2024-07-09 |
CERS
Cerus Corporation
|
Buy |
13.22% |
7.65% |
2024-07-09 |
MCRB
Seres Therapeutics, Inc.
|
Buy |
12.34% |
0.51% |
2024-07-09 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
11.6% |
3.16% |
2024-07-10 |
ATXS
Astria Therapeutics, Inc.
|
Buy |
12.41% |
10.4% |
2024-07-10 |
SNDX
Syndax Pharmaceuticals, Inc.
|
Buy |
11.71% |
4.12% |
2024-07-10 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
11.51% |
2.31% |
2024-07-10 |
BLUE
bluebird bio, Inc.
|
Buy |
12.71% |
13% |
2024-07-10 |
DNLI
Denali Therapeutics Inc.
|
Sell |
-6.15% |
-6.21% |
2024-07-03 |
AGEN
Agenus Inc.
|
Sell |
-5.87% |
-5.92% |
2024-07-04 |
MODV
ModivCare Inc.
|
Sell |
-5.07% |
0.28% |
2024-07-08 |
NUTX
Nutex Health Inc.
|
Sell |
-7.57% |
-9.91% |
2024-07-10 |
The percentage of cash held in the portfolio is:
13.32%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
LXRX |
Buy
All
|
-16.25% |
Assets Rebalanced
None
2024-07-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NKTR
Nektar Therapeutics
|
Buy |
11.65% |
-4.65% |
2024-07-08 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
12.84% |
0.67% |
2024-07-09 |
CERS
Cerus Corporation
|
Buy |
12.88% |
1.02% |
2024-07-09 |
MCRB
Seres Therapeutics, Inc.
|
Buy |
13.37% |
4.83% |
2024-07-09 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
11.68% |
0% |
2024-07-10 |
ATXS
Astria Therapeutics, Inc.
|
Buy |
11.68% |
0% |
2024-07-10 |
SNDX
Syndax Pharmaceuticals, Inc.
|
Buy |
11.68% |
0% |
2024-07-10 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
11.68% |
0% |
2024-07-10 |
BLUE
bluebird bio, Inc.
|
Buy |
11.68% |
0% |
2024-07-10 |
DNLI
Denali Therapeutics Inc.
|
Sell |
-5.8% |
3.59% |
2024-07-03 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-6.02% |
0% |
2024-07-03 |
AGEN
Agenus Inc.
|
Sell |
-6.17% |
-7.23% |
2024-07-04 |
MODV
ModivCare Inc.
|
Sell |
-4.85% |
8.17% |
2024-07-08 |
NUTX
Nutex Health Inc.
|
Sell |
-7.15% |
0% |
2024-07-10 |
The percentage of cash held in the portfolio is:
20.84%
New Assets Added
- TVTX
- ATXS
- SNDX
- SAGE
- BLUE
- NUTX
Assets Removed
None
Assets Rebalanced
None
2024-07-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NKTR
Nektar Therapeutics
|
Buy |
11.89% |
-3.88% |
2024-07-08 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
12.9% |
0% |
2024-07-09 |
CERS
Cerus Corporation
|
Buy |
12.9% |
0% |
2024-07-09 |
MCRB
Seres Therapeutics, Inc.
|
Buy |
12.9% |
0% |
2024-07-09 |
DNLI
Denali Therapeutics Inc.
|
Sell |
-5.93% |
2.53% |
2024-07-03 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-6.09% |
0% |
2024-07-03 |
AGEN
Agenus Inc.
|
Sell |
-6.24% |
-7.09% |
2024-07-04 |
MODV
ModivCare Inc.
|
Sell |
-5.27% |
1.49% |
2024-07-08 |
The percentage of cash held in the portfolio is:
72.93%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
INGN |
Buy
All
|
-14.99% |
Assets Rebalanced
None
2024-07-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NKTR
Nektar Therapeutics
|
Buy |
12.27% |
0% |
2024-07-08 |
INGN
Inogen, Inc.
|
Sell |
-6.5% |
-7.56% |
2024-07-03 |
DNLI
Denali Therapeutics Inc.
|
Sell |
-5.87% |
2.76% |
2024-07-03 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-6.3% |
-4.37% |
2024-07-03 |
AGEN
Agenus Inc.
|
Sell |
-6.02% |
-4.13% |
2024-07-04 |
MODV
ModivCare Inc.
|
Sell |
-5.3% |
0% |
2024-07-08 |
The percentage of cash held in the portfolio is:
117.73%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
INGN
Inogen, Inc.
|
Sell |
-6.34% |
-5.35% |
2024-07-03 |
DNLI
Denali Therapeutics Inc.
|
Sell |
-5.9% |
2.02% |
2024-07-03 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-6.24% |
-3.75% |
2024-07-03 |
AGEN
Agenus Inc.
|
Sell |
-5.76% |
0% |
2024-07-04 |
The percentage of cash held in the portfolio is:
124.24%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
SUPN |
Sell
All
|
NA |
Assets Rebalanced
None
2024-07-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
12.44% |
-2.95% |
2024-06-21 |
INGN
Inogen, Inc.
|
Sell |
-6.34% |
-5.35% |
2024-07-03 |
DNLI
Denali Therapeutics Inc.
|
Sell |
-5.9% |
2.02% |
2024-07-03 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-6.24% |
-3.75% |
2024-07-03 |
AGEN
Agenus Inc.
|
Sell |
-5.76% |
0% |
2024-07-04 |
The percentage of cash held in the portfolio is:
111.8%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
12.29% |
-3.84% |
2024-06-21 |
INGN
Inogen, Inc.
|
Sell |
-6% |
0% |
2024-07-03 |
DNLI
Denali Therapeutics Inc.
|
Sell |
-6% |
0% |
2024-07-03 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-6% |
0% |
2024-07-03 |
The percentage of cash held in the portfolio is:
105.71%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
IBRX |
Sell
All
|
-0.8% |
Assets Rebalanced
None
2024-06-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IBRX
ImmunityBio, Inc.
|
Buy |
13.31% |
4.98% |
2024-06-19 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
12.65% |
0.26% |
2024-06-21 |
The percentage of cash held in the portfolio is:
74.03%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MASI |
Sell
All
|
-1.76% |
TDOC |
Buy
All
|
-1.91% |
Assets Rebalanced
None
2024-06-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MASI
Masimo Corporation
|
Buy |
14.73% |
-1.06% |
2024-06-14 |
IBRX
ImmunityBio, Inc.
|
Buy |
14.56% |
16.69% |
2024-06-19 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
12.28% |
-1.08% |
2024-06-21 |
TDOC
Teladoc Health, Inc.
|
Sell |
-6.03% |
2.01% |
2024-06-14 |
The percentage of cash held in the portfolio is:
64.46%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ACRS |
Sell
All
|
15.18% |
ATRC |
Sell
All
|
-10.48% |
Assets Rebalanced
None
2024-06-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
16.99% |
15.18% |
2024-06-12 |
MASI
Masimo Corporation
|
Buy |
14.33% |
-3.83% |
2024-06-14 |
IBRX
ImmunityBio, Inc.
|
Buy |
14.71% |
17.82% |
2024-06-19 |
ATRC
AtriCure, Inc.
|
Buy |
11.51% |
-7.32% |
2024-06-21 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
12.47% |
0.41% |
2024-06-21 |
TDOC
Teladoc Health, Inc.
|
Sell |
-6.41% |
-4.12% |
2024-06-14 |
The percentage of cash held in the portfolio is:
36.4%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MDGL |
Sell
All
|
11.42% |
ALT |
Buy
All
|
-14.06% |
PEN |
Buy
All
|
7.26% |
Assets Rebalanced
None
2024-06-24 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MDGL
Madrigal Pharmaceuticals, Inc.
|
Buy |
7.29% |
9.24% |
2024-06-11 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
15.53% |
2.68% |
2024-06-12 |
MASI
Masimo Corporation
|
Buy |
14.97% |
-2% |
2024-06-14 |
IBRX
ImmunityBio, Inc.
|
Buy |
14.91% |
16.53% |
2024-06-19 |
ATRC
AtriCure, Inc.
|
Buy |
12.29% |
-3.49% |
2024-06-21 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
12.85% |
0.9% |
2024-06-21 |
ALT
Altimmune, Inc.
|
Sell |
12.54% |
-2.4% |
2024-06-11 |
PEN
Penumbra, Inc.
|
Sell |
-5.56% |
5.05% |
2024-06-11 |
TDOC
Teladoc Health, Inc.
|
Sell |
-6.16% |
2.41% |
2024-06-14 |
The percentage of cash held in the portfolio is:
21.34%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
MCRB |
Buy
All
|
-26.38% |
ABUS |
Buy
All
|
4.69% |
Assets Rebalanced
None
2024-06-21 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MDGL
Madrigal Pharmaceuticals, Inc.
|
Buy |
7.07% |
5.07% |
2024-06-11 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
15.39% |
0.89% |
2024-06-12 |
MASI
Masimo Corporation
|
Buy |
15.01% |
-2.58% |
2024-06-14 |
IBRX
ImmunityBio, Inc.
|
Buy |
13.46% |
4.33% |
2024-06-19 |
ATRC
AtriCure, Inc.
|
Buy |
12.84% |
0% |
2024-06-21 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
12.84% |
0% |
2024-06-21 |
MCRB
Seres Therapeutics, Inc.
|
Sell |
-7.94% |
-22.48% |
2024-06-10 |
ABUS
Arbutus Biopharma Corporation
|
Sell |
-5.98% |
7.81% |
2024-06-10 |
PEN
Penumbra, Inc.
|
Sell |
-5.51% |
6.71% |
2024-06-11 |
ALT
Altimmune, Inc.
|
Sell |
-5.61% |
5.11% |
2024-06-11 |
TDOC
Teladoc Health, Inc.
|
Sell |
-6.18% |
3.02% |
2024-06-14 |
The percentage of cash held in the portfolio is:
54.59%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SGRY |
Sell
All
|
-11.04% |
PDSB |
Sell
All
|
-15% |
Assets Rebalanced
None
2024-06-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MDGL
Madrigal Pharmaceuticals, Inc.
|
Buy |
7.14% |
8.29% |
2024-06-11 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
15.08% |
0.89% |
2024-06-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
13.44% |
-5.93% |
2024-06-13 |
MASI
Masimo Corporation
|
Buy |
15.32% |
1.46% |
2024-06-14 |
PDSB
PDS Biotechnology Corporation
|
Buy |
13.79% |
-8.67% |
2024-06-14 |
IBRX
ImmunityBio, Inc.
|
Buy |
12.65% |
0% |
2024-06-19 |
MCRB
Seres Therapeutics, Inc.
|
Sell |
-7.34% |
-15.64% |
2024-06-10 |
ABUS
Arbutus Biopharma Corporation
|
Sell |
-5.97% |
5.94% |
2024-06-10 |
PEN
Penumbra, Inc.
|
Sell |
-5.42% |
6.4% |
2024-06-11 |
ALT
Altimmune, Inc.
|
Sell |
-5.47% |
5.59% |
2024-06-11 |
TDOC
Teladoc Health, Inc.
|
Sell |
-6.33% |
-1.41% |
2024-06-14 |
The percentage of cash held in the portfolio is:
53.12%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ARWR |
Sell
All
|
-8.52% |
Assets Rebalanced
None
2024-06-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MDGL
Madrigal Pharmaceuticals, Inc.
|
Buy |
7.13% |
8.57% |
2024-06-11 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
15.01% |
0.89% |
2024-06-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
13.43% |
-5.63% |
2024-06-13 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
13.86% |
-2.6% |
2024-06-13 |
MASI
Masimo Corporation
|
Buy |
15.2% |
1.11% |
2024-06-14 |
PDSB
PDS Biotechnology Corporation
|
Buy |
13.38% |
-11% |
2024-06-14 |
MCRB
Seres Therapeutics, Inc.
|
Sell |
-6.91% |
-9.28% |
2024-06-10 |
ABUS
Arbutus Biopharma Corporation
|
Sell |
-6.05% |
4.38% |
2024-06-10 |
PEN
Penumbra, Inc.
|
Sell |
-5.74% |
0.39% |
2024-06-11 |
ALT
Altimmune, Inc.
|
Sell |
-5.45% |
5.43% |
2024-06-11 |
TDOC
Teladoc Health, Inc.
|
Sell |
-6.31% |
-1.61% |
2024-06-14 |
The percentage of cash held in the portfolio is:
52.46%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AGIO |
Sell
All
|
-10.05% |
Assets Rebalanced
None
2024-06-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AGIO
Agios Pharmaceuticals, Inc.
|
Buy |
10.6% |
-6.84% |
2024-06-05 |
MDGL
Madrigal Pharmaceuticals, Inc.
|
Buy |
7.06% |
8.91% |
2024-06-11 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
15.47% |
5.36% |
2024-06-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
13.18% |
-6.12% |
2024-06-13 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
14.08% |
0.27% |
2024-06-13 |
MASI
Masimo Corporation
|
Buy |
15.03% |
1.37% |
2024-06-14 |
PDSB
PDS Biotechnology Corporation
|
Buy |
13.77% |
-7.17% |
2024-06-14 |
MCRB
Seres Therapeutics, Inc.
|
Sell |
-7.19% |
-15.31% |
2024-06-10 |
ABUS
Arbutus Biopharma Corporation
|
Sell |
-6.12% |
1.87% |
2024-06-10 |
PEN
Penumbra, Inc.
|
Sell |
-5.68% |
0.15% |
2024-06-11 |
ALT
Altimmune, Inc.
|
Sell |
-5.55% |
2.4% |
2024-06-11 |
TDOC
Teladoc Health, Inc.
|
Sell |
-6.16% |
-0.5% |
2024-06-14 |
The percentage of cash held in the portfolio is:
41.52%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
EDIT |
Sell
All
|
-16.23% |
RARE |
Sell
All
|
-2.72% |
Assets Rebalanced
None
2024-06-14 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
13.64% |
7.42% |
2024-06-03 |
AGIO
Agios Pharmaceuticals, Inc.
|
Buy |
10.81% |
-1.22% |
2024-06-05 |
MDGL
Madrigal Pharmaceuticals, Inc.
|
Buy |
6.77% |
8.69% |
2024-06-11 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
15% |
6.25% |
2024-06-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
12.84% |
-4.92% |
2024-06-13 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
13.88% |
2.83% |
2024-06-13 |
EDIT
Editas Medicine, Inc.
|
Buy |
12.27% |
-9.11% |
2024-06-13 |
MASI
Masimo Corporation
|
Buy |
14.26% |
0% |
2024-06-14 |
PDSB
PDS Biotechnology Corporation
|
Buy |
14.26% |
0% |
2024-06-14 |
MCRB
Seres Therapeutics, Inc.
|
Sell |
-6.94% |
-15.64% |
2024-06-10 |
ABUS
Arbutus Biopharma Corporation
|
Sell |
-5.92% |
1.25% |
2024-06-10 |
PEN
Penumbra, Inc.
|
Sell |
-5.47% |
0.03% |
2024-06-11 |
ALT
Altimmune, Inc.
|
Sell |
-5.78% |
-5.59% |
2024-06-11 |
TDOC
Teladoc Health, Inc.
|
Sell |
-5.89% |
0% |
2024-06-14 |
The percentage of cash held in the portfolio is:
16.26%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
IRMD |
Sell
All
|
-2.14% |
FOLD |
Sell
All
|
7.79% |
ESPR |
Sell
All
|
27.07% |
STAA |
Buy
All
|
-8.41% |
Assets Rebalanced
None
2024-06-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
FOLD
Amicus Therapeutics, Inc.
|
Buy |
13.41% |
7.69% |
2024-05-31 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
15.72% |
26.2% |
2024-05-31 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
13.87% |
11.21% |
2024-06-03 |
AGIO
Agios Pharmaceuticals, Inc.
|
Buy |
10.89% |
1.31% |
2024-06-05 |
MDGL
Madrigal Pharmaceuticals, Inc.
|
Buy |
6.86% |
12.14% |
2024-06-11 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
14.23% |
2.68% |
2024-06-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
13.26% |
0% |
2024-06-13 |
IRMD
IRadimed Corporation
|
Buy |
13.26% |
0% |
2024-06-13 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
13.26% |
0% |
2024-06-13 |
EDIT
Editas Medicine, Inc.
|
Buy |
13.26% |
0% |
2024-06-13 |
STAA
STAAR Surgical Company
|
Sell |
-6.25% |
-6.18% |
2024-06-10 |
MCRB
Seres Therapeutics, Inc.
|
Sell |
-7.15% |
-21.43% |
2024-06-10 |
ABUS
Arbutus Biopharma Corporation
|
Sell |
-5.98% |
-1.56% |
2024-06-10 |
PEN
Penumbra, Inc.
|
Sell |
-5.48% |
-1.97% |
2024-06-11 |
ALT
Altimmune, Inc.
|
Sell |
-5.47% |
-1.92% |
2024-06-11 |
The percentage of cash held in the portfolio is:
2.34%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
MDRX |
Sell
All
|
0% |
ANIK |
Sell
All
|
1.79% |
TVTX |
Sell
All
|
7.31% |
Assets Rebalanced
None
2024-06-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Buy |
12.74% |
0% |
2024-05-30 |
ANIK
Anika Therapeutics, Inc.
|
Buy |
12.85% |
0.86% |
2024-05-30 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
13.17% |
3.36% |
2024-05-30 |
FOLD
Amicus Therapeutics, Inc.
|
Buy |
13.41% |
5.26% |
2024-05-31 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
16.13% |
26.64% |
2024-05-31 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
13.15% |
3.14% |
2024-06-03 |
AGIO
Agios Pharmaceuticals, Inc.
|
Buy |
11.03% |
0.34% |
2024-06-05 |
MDGL
Madrigal Pharmaceuticals, Inc.
|
Buy |
7.17% |
14.56% |
2024-06-11 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
14.17% |
0% |
2024-06-12 |
STAA
STAAR Surgical Company
|
Sell |
-6.03% |
-0.16% |
2024-06-10 |
MCRB
Seres Therapeutics, Inc.
|
Sell |
-7.8% |
-29.43% |
2024-06-10 |
ABUS
Arbutus Biopharma Corporation
|
Sell |
-5.99% |
0.62% |
2024-06-10 |
PEN
Penumbra, Inc.
|
Sell |
-5.55% |
-1% |
2024-06-11 |
ALT
Altimmune, Inc.
|
Sell |
-5.68% |
-3.51% |
2024-06-11 |
The percentage of cash held in the portfolio is:
17.22%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
DVA |
Sell
All
|
-4.66% |
Assets Rebalanced
None
2024-06-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Buy |
12.77% |
0.53% |
2024-05-30 |
DVA
DaVita Inc.
|
Buy |
12.26% |
-3.48% |
2024-05-30 |
ANIK
Anika Therapeutics, Inc.
|
Buy |
12.74% |
0.27% |
2024-05-30 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
13.51% |
6.29% |
2024-05-30 |
FOLD
Amicus Therapeutics, Inc.
|
Buy |
12.92% |
1.72% |
2024-05-31 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
16.14% |
27.07% |
2024-05-31 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
13.3% |
4.56% |
2024-06-03 |
AGIO
Agios Pharmaceuticals, Inc.
|
Buy |
10.93% |
-0.27% |
2024-06-05 |
MDGL
Madrigal Pharmaceuticals, Inc.
|
Buy |
6.24% |
0% |
2024-06-11 |
STAA
STAAR Surgical Company
|
Sell |
-5.92% |
1.53% |
2024-06-10 |
MCRB
Seres Therapeutics, Inc.
|
Sell |
-7.24% |
-20.52% |
2024-06-10 |
ABUS
Arbutus Biopharma Corporation
|
Sell |
-5.89% |
1.87% |
2024-06-10 |
PEN
Penumbra, Inc.
|
Sell |
-5.48% |
0% |
2024-06-11 |
ALT
Altimmune, Inc.
|
Sell |
-5.48% |
0% |
2024-06-11 |
The percentage of cash held in the portfolio is:
19.19%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Buy |
12.63% |
-0.53% |
2024-05-30 |
DVA
DaVita Inc.
|
Buy |
12.39% |
-2.39% |
2024-05-30 |
ANIK
Anika Therapeutics, Inc.
|
Buy |
12.77% |
0.59% |
2024-05-30 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
13.23% |
4.24% |
2024-05-30 |
FOLD
Amicus Therapeutics, Inc.
|
Buy |
12.9% |
1.72% |
2024-05-31 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
15.51% |
22.27% |
2024-05-31 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
13.1% |
3.14% |
2024-06-03 |
AGIO
Agios Pharmaceuticals, Inc.
|
Buy |
11.01% |
0.55% |
2024-06-05 |
STAA
STAAR Surgical Company
|
Sell |
-6% |
0% |
2024-06-10 |
MCRB
Seres Therapeutics, Inc.
|
Sell |
-6% |
0% |
2024-06-10 |
ABUS
Arbutus Biopharma Corporation
|
Sell |
-6% |
0% |
2024-06-10 |
The percentage of cash held in the portfolio is:
14.46%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
TNDM |
Sell
All
|
-5.57% |
CUTR |
Buy
All
|
6.8% |
CARA |
Buy
All
|
7% |
CPRX |
Buy
All
|
1.58% |
VERU |
Buy
All
|
25.2% |
SENS |
Buy
All
|
7.66% |
Assets Rebalanced
None
2024-06-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
9.19% |
-4.18% |
2024-05-27 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Buy |
12.85% |
0% |
2024-05-30 |
DVA
DaVita Inc.
|
Buy |
12.6% |
-1.94% |
2024-05-30 |
ANIK
Anika Therapeutics, Inc.
|
Buy |
13.15% |
2.34% |
2024-05-30 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
13.58% |
5.7% |
2024-05-30 |
FOLD
Amicus Therapeutics, Inc.
|
Buy |
13.34% |
3.95% |
2024-05-31 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
13.85% |
7.86% |
2024-05-31 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
13.38% |
4.06% |
2024-06-03 |
AGIO
Agios Pharmaceuticals, Inc.
|
Buy |
11.18% |
0.95% |
2024-06-05 |
CUTR
Cutera, Inc.
|
Sell |
-5.58% |
4.85% |
2024-05-27 |
CARA
Cara Therapeutics, Inc.
|
Sell |
-5.62% |
4.32% |
2024-05-27 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-5.83% |
0.69% |
2024-05-27 |
VERU
Veru Inc.
|
Sell |
-4.39% |
25.2% |
2024-05-27 |
SENS
Senseonics Holdings, Inc.
|
Sell |
-5.57% |
5.18% |
2024-05-27 |
The percentage of cash held in the portfolio is:
13.88%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MD |
Sell
All
|
-7.14% |
Assets Rebalanced
None
2024-06-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
9.56% |
-1.04% |
2024-05-27 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Buy |
13.12% |
1.37% |
2024-05-30 |
DVA
DaVita Inc.
|
Buy |
12.65% |
-2.3% |
2024-05-30 |
ANIK
Anika Therapeutics, Inc.
|
Buy |
13.32% |
2.93% |
2024-05-30 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
14.52% |
12.13% |
2024-05-30 |
FOLD
Amicus Therapeutics, Inc.
|
Buy |
13.25% |
2.43% |
2024-05-31 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
12.71% |
-1.75% |
2024-05-31 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
13.21% |
1.94% |
2024-06-03 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
12.76% |
-1.21% |
2024-06-04 |
AGIO
Agios Pharmaceuticals, Inc.
|
Buy |
11.16% |
0% |
2024-06-05 |
CUTR
Cutera, Inc.
|
Sell |
-5.97% |
-0.97% |
2024-05-27 |
CARA
Cara Therapeutics, Inc.
|
Sell |
-5.85% |
1.04% |
2024-05-27 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-5.98% |
-1.07% |
2024-05-27 |
VERU
Veru Inc.
|
Sell |
-4.86% |
17.89% |
2024-05-27 |
SENS
Senseonics Holdings, Inc.
|
Sell |
-5.6% |
5.41% |
2024-05-27 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
VKTX |
Sell
All
|
-13.97% |
Assets Rebalanced
None
2024-06-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
9.58% |
0.48% |
2024-05-27 |
VKTX
Viking Therapeutics, Inc.
|
Buy |
12.17% |
-4.73% |
2024-05-29 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Buy |
12.91% |
1.05% |
2024-05-30 |
DVA
DaVita Inc.
|
Buy |
12.68% |
-0.74% |
2024-05-30 |
ANIK
Anika Therapeutics, Inc.
|
Buy |
13.3% |
4.06% |
2024-05-30 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
14.42% |
12.87% |
2024-05-30 |
FOLD
Amicus Therapeutics, Inc.
|
Buy |
12.96% |
1.52% |
2024-05-31 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
12.49% |
-2.18% |
2024-05-31 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
13.1% |
2.47% |
2024-06-03 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
12.75% |
0% |
2024-06-04 |
CUTR
Cutera, Inc.
|
Sell |
-6.32% |
-8.25% |
2024-05-27 |
CARA
Cara Therapeutics, Inc.
|
Sell |
-5.92% |
-1.34% |
2024-05-27 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-5.95% |
-1.95% |
2024-05-27 |
VERU
Veru Inc.
|
Sell |
-4.79% |
17.89% |
2024-05-27 |
SENS
Senseonics Holdings, Inc.
|
Sell |
-5.39% |
7.66% |
2024-05-27 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
9.64% |
-0.97% |
2024-05-27 |
VKTX
Viking Therapeutics, Inc.
|
Buy |
12.43% |
-4.74% |
2024-05-29 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Buy |
13.04% |
0% |
2024-05-30 |
DVA
DaVita Inc.
|
Buy |
13.08% |
0.29% |
2024-05-30 |
ANIK
Anika Therapeutics, Inc.
|
Buy |
13.05% |
0.04% |
2024-05-30 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
14.15% |
8.48% |
2024-05-30 |
FOLD
Amicus Therapeutics, Inc.
|
Buy |
12.93% |
-0.81% |
2024-05-31 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
12.3% |
-5.68% |
2024-05-31 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
13.05% |
0% |
2024-06-03 |
CUTR
Cutera, Inc.
|
Sell |
-6.22% |
-4.37% |
2024-05-27 |
CARA
Cara Therapeutics, Inc.
|
Sell |
-5.76% |
3.28% |
2024-05-27 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-6.07% |
-1.89% |
2024-05-27 |
VERU
Veru Inc.
|
Sell |
-4.89% |
17.89% |
2024-05-27 |
SENS
Senseonics Holdings, Inc.
|
Sell |
-5.77% |
3.15% |
2024-05-27 |
The percentage of cash held in the portfolio is:
15.05%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-31 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
9.89% |
3.29% |
2024-05-27 |
VKTX
Viking Therapeutics, Inc.
|
Buy |
12.13% |
-5.48% |
2024-05-29 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Buy |
13.19% |
2.74% |
2024-05-30 |
DVA
DaVita Inc.
|
Buy |
12.87% |
0.31% |
2024-05-30 |
ANIK
Anika Therapeutics, Inc.
|
Buy |
12.87% |
0.27% |
2024-05-30 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
13.17% |
2.63% |
2024-05-30 |
FOLD
Amicus Therapeutics, Inc.
|
Buy |
12.83% |
0% |
2024-05-31 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
12.83% |
0% |
2024-05-31 |
CUTR
Cutera, Inc.
|
Sell |
-5.92% |
-0.97% |
2024-05-27 |
CARA
Cara Therapeutics, Inc.
|
Sell |
-5.23% |
10.88% |
2024-05-27 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-5.95% |
-1.51% |
2024-05-27 |
VERU
Veru Inc.
|
Sell |
-4.62% |
21.14% |
2024-05-27 |
SENS
Senseonics Holdings, Inc.
|
Sell |
-5.71% |
2.7% |
2024-05-27 |
The percentage of cash held in the portfolio is:
27.65%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
9.73% |
0.04% |
2024-05-27 |
VKTX
Viking Therapeutics, Inc.
|
Buy |
12.72% |
-2.37% |
2024-05-29 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Buy |
13.03% |
0% |
2024-05-30 |
DVA
DaVita Inc.
|
Buy |
13.03% |
0% |
2024-05-30 |
ANIK
Anika Therapeutics, Inc.
|
Buy |
13.03% |
0% |
2024-05-30 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
13.03% |
0% |
2024-05-30 |
CUTR
Cutera, Inc.
|
Sell |
-6.5% |
-9.22% |
2024-05-27 |
CARA
Cara Therapeutics, Inc.
|
Sell |
-5.47% |
8.05% |
2024-05-27 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-5.96% |
-0.06% |
2024-05-27 |
VERU
Veru Inc.
|
Sell |
-4.84% |
18.7% |
2024-05-27 |
SENS
Senseonics Holdings, Inc.
|
Sell |
-5.9% |
0.9% |
2024-05-27 |
The percentage of cash held in the portfolio is:
54.11%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
9.94% |
2.26% |
2024-05-27 |
VKTX
Viking Therapeutics, Inc.
|
Buy |
13.03% |
0% |
2024-05-29 |
CUTR
Cutera, Inc.
|
Sell |
-5.84% |
1.94% |
2024-05-27 |
CARA
Cara Therapeutics, Inc.
|
Sell |
-5.96% |
-0.15% |
2024-05-27 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-6.22% |
-4.41% |
2024-05-27 |
VERU
Veru Inc.
|
Sell |
-5.37% |
9.76% |
2024-05-27 |
SENS
Senseonics Holdings, Inc.
|
Sell |
-5.83% |
2.03% |
2024-05-27 |
The percentage of cash held in the portfolio is:
106.25%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
9.8% |
0% |
2024-05-27 |
CUTR
Cutera, Inc.
|
Sell |
-6% |
0% |
2024-05-27 |
CARA
Cara Therapeutics, Inc.
|
Sell |
-6% |
0% |
2024-05-27 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-6% |
0% |
2024-05-27 |
VERU
Veru Inc.
|
Sell |
-6% |
0% |
2024-05-27 |
SENS
Senseonics Holdings, Inc.
|
Sell |
-6% |
0% |
2024-05-27 |
The percentage of cash held in the portfolio is:
120.2%
New Assets Added
- TNDM
- CUTR
- CARA
- CPRX
- VERU
- SENS
Assets Removed
None
Assets Rebalanced
None
2024-05-10 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
HCSG |
Buy
All
|
-1.82% |
Assets Rebalanced
None
2024-05-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
HCSG
Healthcare Services Group, Inc.
|
Sell |
3.35% |
0% |
2024-04-26 |
The percentage of cash held in the portfolio is:
96.65%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ADUS |
Sell
All
|
12.14% |
Assets Rebalanced
None
2024-05-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ADUS
Addus HomeCare Corporation
|
Buy |
13.19% |
9.52% |
2024-04-25 |
HCSG
Healthcare Services Group, Inc.
|
Sell |
3.31% |
1.64% |
2024-04-26 |
The percentage of cash held in the portfolio is:
83.5%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ANIP |
Sell
All
|
0.88% |
BGNE |
Sell
All
|
15.52% |
CYH |
Sell
All
|
13.85% |
Assets Rebalanced
None
2024-05-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ANIP
ANI Pharmaceuticals, Inc.
|
Buy |
12.38% |
1.84% |
2024-04-24 |
BGNE
BeiGene, Ltd.
|
Buy |
14.21% |
16.9% |
2024-04-24 |
CYH
Community Health Systems, Inc.
|
Buy |
13.88% |
14.19% |
2024-04-24 |
ADUS
Addus HomeCare Corporation
|
Buy |
12.41% |
2.5% |
2024-04-25 |
HCSG
Healthcare Services Group, Inc.
|
Sell |
3.33% |
1.55% |
2024-04-26 |
The percentage of cash held in the portfolio is:
43.79%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BLFS |
Sell
All
|
8.04% |
Assets Rebalanced
None
2024-05-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BLFS
BioLife Solutions, Inc.
|
Buy |
13.14% |
4.4% |
2024-04-23 |
ANIP
ANI Pharmaceuticals, Inc.
|
Buy |
12.38% |
-0.21% |
2024-04-24 |
BGNE
BeiGene, Ltd.
|
Buy |
13.75% |
10.76% |
2024-04-24 |
CYH
Community Health Systems, Inc.
|
Buy |
13.84% |
11.49% |
2024-04-24 |
ADUS
Addus HomeCare Corporation
|
Buy |
12.45% |
0.68% |
2024-04-25 |
HCSG
Healthcare Services Group, Inc.
|
Sell |
3.33% |
3.45% |
2024-04-26 |
The percentage of cash held in the portfolio is:
31.12%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BRKR |
Sell
All
|
-5.4% |
TDOC |
Buy
All
|
2.89% |
Assets Rebalanced
None
2024-04-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BLFS
BioLife Solutions, Inc.
|
Buy |
13.42% |
6.31% |
2024-04-23 |
ANIP
ANI Pharmaceuticals, Inc.
|
Buy |
12.33% |
-0.97% |
2024-04-24 |
BGNE
BeiGene, Ltd.
|
Buy |
14.02% |
12.62% |
2024-04-24 |
BRKR
Bruker Corporation
|
Buy |
12.27% |
-1.46% |
2024-04-24 |
CYH
Community Health Systems, Inc.
|
Buy |
13.84% |
11.15% |
2024-04-24 |
ADUS
Addus HomeCare Corporation
|
Buy |
12.23% |
-1.38% |
2024-04-25 |
TDOC
Teladoc Health, Inc.
|
Sell |
-20.58% |
-1.98% |
2024-04-17 |
HCSG
Healthcare Services Group, Inc.
|
Sell |
3.42% |
1.27% |
2024-04-26 |
The percentage of cash held in the portfolio is:
39.04%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
SGMO |
Sell
All
|
-7.14% |
AADI |
Buy
All
|
-10.71% |
Assets Rebalanced
None
2024-04-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
12.82% |
-7.14% |
2024-04-16 |
BLFS
BioLife Solutions, Inc.
|
Buy |
13.14% |
4.35% |
2024-04-23 |
ANIP
ANI Pharmaceuticals, Inc.
|
Buy |
12.28% |
-1.18% |
2024-04-24 |
BGNE
BeiGene, Ltd.
|
Buy |
13.73% |
10.5% |
2024-04-24 |
BRKR
Bruker Corporation
|
Buy |
12.2% |
-1.81% |
2024-04-24 |
CYH
Community Health Systems, Inc.
|
Buy |
14.23% |
14.53% |
2024-04-24 |
ADUS
Addus HomeCare Corporation
|
Buy |
12.25% |
-1.01% |
2024-04-25 |
TDOC
Teladoc Health, Inc.
|
Sell |
-19.95% |
0.91% |
2024-04-17 |
HCSG
Healthcare Services Group, Inc.
|
Sell |
3.41% |
1.36% |
2024-04-26 |
AADI
Aadi Bioscience, Inc.
|
Sell |
3.6% |
-4.17% |
2024-04-26 |
The percentage of cash held in the portfolio is:
22.3%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ORMP |
Buy
All
|
-11.82% |
Assets Rebalanced
None
2024-04-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
12.55% |
-10.71% |
2024-04-16 |
BLFS
BioLife Solutions, Inc.
|
Buy |
12.87% |
0.36% |
2024-04-23 |
ANIP
ANI Pharmaceuticals, Inc.
|
Buy |
12.42% |
-1.8% |
2024-04-24 |
BGNE
BeiGene, Ltd.
|
Buy |
13.52% |
6.89% |
2024-04-24 |
BRKR
Bruker Corporation
|
Buy |
12.36% |
-2.27% |
2024-04-24 |
CYH
Community Health Systems, Inc.
|
Buy |
13.89% |
9.8% |
2024-04-24 |
ADUS
Addus HomeCare Corporation
|
Buy |
12.1% |
-3.98% |
2024-04-25 |
TDOC
Teladoc Health, Inc.
|
Sell |
-20.81% |
-1.52% |
2024-04-17 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-19.74% |
-4.55% |
2024-04-19 |
HCSG
Healthcare Services Group, Inc.
|
Sell |
3.52% |
0% |
2024-04-26 |
AADI
Aadi Bioscience, Inc.
|
Sell |
3.52% |
0% |
2024-04-26 |
The percentage of cash held in the portfolio is:
43.82%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ATRI |
Buy
All
|
1.02% |
AVNS |
Buy
All
|
6.89% |
BLUE |
Buy
All
|
21.55% |
Assets Rebalanced
None
2024-04-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
12.4% |
-12.5% |
2024-04-16 |
BLFS
BioLife Solutions, Inc.
|
Buy |
13.22% |
2.32% |
2024-04-23 |
ANIP
ANI Pharmaceuticals, Inc.
|
Buy |
12.61% |
-1.07% |
2024-04-24 |
BGNE
BeiGene, Ltd.
|
Buy |
13.22% |
3.69% |
2024-04-24 |
BRKR
Bruker Corporation
|
Buy |
12.71% |
-0.32% |
2024-04-24 |
CYH
Community Health Systems, Inc.
|
Buy |
13.05% |
2.36% |
2024-04-24 |
ADUS
Addus HomeCare Corporation
|
Buy |
12.7% |
0% |
2024-04-25 |
ATRI
Atrion Corporation
|
Sell |
12.7% |
-5.23% |
2024-04-12 |
AVNS
Avanos Medical, Inc.
|
Sell |
3.44% |
2.4% |
2024-04-12 |
BLUE
bluebird bio, Inc.
|
Sell |
2.79% |
20.69% |
2024-04-12 |
TDOC
Teladoc Health, Inc.
|
Sell |
-21.6% |
-4.57% |
2024-04-17 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-20.5% |
-7.73% |
2024-04-19 |
The percentage of cash held in the portfolio is:
33.27%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-04-24 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
13.13% |
-7.14% |
2024-04-16 |
BLFS
BioLife Solutions, Inc.
|
Buy |
13.07% |
1.31% |
2024-04-23 |
CYH
Community Health Systems, Inc.
|
Buy |
12.72% |
0% |
2024-04-24 |
BRKR
Bruker Corporation
|
Buy |
12.72% |
0% |
2024-04-24 |
BGNE
BeiGene, Ltd.
|
Buy |
12.72% |
0% |
2024-04-24 |
ANIP
ANI Pharmaceuticals, Inc.
|
Buy |
12.72% |
0% |
2024-04-24 |
ATRI
Atrion Corporation
|
Sell |
3.53% |
-0.54% |
2024-04-12 |
AVNS
Avanos Medical, Inc.
|
Sell |
3.44% |
2.14% |
2024-04-12 |
BLUE
bluebird bio, Inc.
|
Sell |
2.94% |
16.38% |
2024-04-12 |
TDOC
Teladoc Health, Inc.
|
Sell |
-21.58% |
-4.65% |
2024-04-17 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-20.29% |
-6.82% |
2024-04-19 |
The percentage of cash held in the portfolio is:
54.86%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
KIDS |
Sell
All
|
0.76% |
Assets Rebalanced
None
2024-04-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
KIDS
OrthoPediatrics Corp.
|
Buy |
12.15% |
-0.66% |
2024-04-10 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
12.86% |
-8.93% |
2024-04-16 |
BLFS
BioLife Solutions, Inc.
|
Buy |
12.87% |
0% |
2024-04-23 |
ATRI
Atrion Corporation
|
Sell |
3.48% |
0.81% |
2024-04-12 |
AVNS
Avanos Medical, Inc.
|
Sell |
3.47% |
1.15% |
2024-04-12 |
BLUE
bluebird bio, Inc.
|
Sell |
2.87% |
18.1% |
2024-04-12 |
TDOC
Teladoc Health, Inc.
|
Sell |
-20.85% |
-1.29% |
2024-04-17 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-20.08% |
-5.91% |
2024-04-19 |
The percentage of cash held in the portfolio is:
93.23%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ORGO |
Sell
All
|
0% |
PODD |
Sell
All
|
-3.31% |
Assets Rebalanced
None
2024-04-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ORGO
Organogenesis Holdings Inc.
|
Buy |
11.99% |
-3.7% |
2024-04-09 |
PODD
Insulet Corporation
|
Buy |
11.33% |
-3.12% |
2024-04-09 |
KIDS
OrthoPediatrics Corp.
|
Buy |
11.86% |
-3.09% |
2024-04-10 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
12.36% |
-12.5% |
2024-04-16 |
ATRI
Atrion Corporation
|
Sell |
3.36% |
4.32% |
2024-04-12 |
AVNS
Avanos Medical, Inc.
|
Sell |
3.42% |
2.45% |
2024-04-12 |
BLUE
bluebird bio, Inc.
|
Sell |
2.87% |
18.1% |
2024-04-12 |
TDOC
Teladoc Health, Inc.
|
Sell |
-20.68% |
-0.38% |
2024-04-17 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-18.98% |
0% |
2024-04-19 |
The percentage of cash held in the portfolio is:
82.46%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
MDGL |
Sell
All
|
-10.86% |
GKOS |
Sell
All
|
-5.47% |
CDXS |
Buy
All
|
12.77% |
Assets Rebalanced
None
2024-04-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ORGO
Organogenesis Holdings Inc.
|
Buy |
11.55% |
-3.7% |
2024-04-09 |
GKOS
Glaukos Corporation
|
Buy |
11.29% |
-3.66% |
2024-04-09 |
PODD
Insulet Corporation
|
Buy |
11.45% |
1.57% |
2024-04-09 |
KIDS
OrthoPediatrics Corp.
|
Buy |
11.71% |
-0.72% |
2024-04-10 |
MDGL
Madrigal Pharmaceuticals, Inc.
|
Buy |
11.02% |
-6.56% |
2024-04-10 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
13.13% |
-3.57% |
2024-04-16 |
CDXS
Codexis, Inc.
|
Sell |
-19.76% |
14.95% |
2024-04-05 |
ATRI
Atrion Corporation
|
Sell |
3.43% |
-1.5% |
2024-04-12 |
AVNS
Avanos Medical, Inc.
|
Sell |
3.29% |
2.71% |
2024-04-12 |
BLUE
bluebird bio, Inc.
|
Sell |
2.89% |
14.66% |
2024-04-12 |
TDOC
Teladoc Health, Inc.
|
Sell |
-19.85% |
0% |
2024-04-17 |
The percentage of cash held in the portfolio is:
59.85%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
NKTR |
Sell
All
|
-10.78% |
SMTI |
Buy
All
|
10.11% |
Assets Rebalanced
None
2024-04-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ORGO
Organogenesis Holdings Inc.
|
Buy |
11.04% |
-7.07% |
2024-04-09 |
GKOS
Glaukos Corporation
|
Buy |
11.16% |
-3.77% |
2024-04-09 |
PODD
Insulet Corporation
|
Buy |
11.41% |
2.29% |
2024-04-09 |
KIDS
OrthoPediatrics Corp.
|
Buy |
11.69% |
0.16% |
2024-04-10 |
MDGL
Madrigal Pharmaceuticals, Inc.
|
Buy |
10.83% |
-7.21% |
2024-04-10 |
NKTR
Nektar Therapeutics
|
Buy |
16.78% |
-5.99% |
2024-04-15 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
13.48% |
0% |
2024-04-16 |
SMTI
Sanara MedTech Inc.
|
Sell |
-19.13% |
8.41% |
2024-04-03 |
CDXS
Codexis, Inc.
|
Sell |
-19.27% |
16.2% |
2024-04-05 |
ATRI
Atrion Corporation
|
Sell |
3.31% |
1.1% |
2024-04-12 |
AVNS
Avanos Medical, Inc.
|
Sell |
3.29% |
1.67% |
2024-04-12 |
BLUE
bluebird bio, Inc.
|
Sell |
2.97% |
11.21% |
2024-04-12 |
The percentage of cash held in the portfolio is:
42.43%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SAVA |
Sell
All
|
-15.1% |
TDOC |
Sell
All
|
-10.03% |
BCRX |
Sell
All
|
-8.43% |
Assets Rebalanced
None
2024-04-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ORGO
Organogenesis Holdings Inc.
|
Buy |
11.23% |
-3.03% |
2024-04-09 |
GKOS
Glaukos Corporation
|
Buy |
11.04% |
-2.38% |
2024-04-09 |
PODD
Insulet Corporation
|
Buy |
11.21% |
3.05% |
2024-04-09 |
SAVA
Cassava Sciences, Inc.
|
Buy |
10.2% |
-3.48% |
2024-04-09 |
TDOC
Teladoc Health, Inc.
|
Buy |
10.75% |
-5.64% |
2024-04-10 |
KIDS
OrthoPediatrics Corp.
|
Buy |
11.65% |
2.27% |
2024-04-10 |
MDGL
Madrigal Pharmaceuticals, Inc.
|
Buy |
10.81% |
-5.11% |
2024-04-10 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
16.25% |
-6.47% |
2024-04-12 |
NKTR
Nektar Therapeutics
|
Buy |
17.41% |
0% |
2024-04-15 |
SMTI
Sanara MedTech Inc.
|
Sell |
-19.4% |
4.8% |
2024-04-03 |
CDXS
Codexis, Inc.
|
Sell |
-20.05% |
10.59% |
2024-04-05 |
ATRI
Atrion Corporation
|
Sell |
3.24% |
0.93% |
2024-04-12 |
AVNS
Avanos Medical, Inc.
|
Sell |
3.15% |
3.44% |
2024-04-12 |
BLUE
bluebird bio, Inc.
|
Sell |
3.1% |
5.17% |
2024-04-12 |
The percentage of cash held in the portfolio is:
19.41%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-04-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ORGO
Organogenesis Holdings Inc.
|
Buy |
11.32% |
1.01% |
2024-04-09 |
GKOS
Glaukos Corporation
|
Buy |
10.8% |
-1.36% |
2024-04-09 |
PODD
Insulet Corporation
|
Buy |
11.12% |
5.65% |
2024-04-09 |
SAVA
Cassava Sciences, Inc.
|
Buy |
11.33% |
10.78% |
2024-04-09 |
TDOC
Teladoc Health, Inc.
|
Buy |
10.69% |
-3.05% |
2024-04-10 |
KIDS
OrthoPediatrics Corp.
|
Buy |
11.44% |
3.82% |
2024-04-10 |
MDGL
Madrigal Pharmaceuticals, Inc.
|
Buy |
10.84% |
-1.63% |
2024-04-10 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
16.82% |
0% |
2024-04-12 |
SMTI
Sanara MedTech Inc.
|
Sell |
-18.45% |
6.42% |
2024-04-03 |
CDXS
Codexis, Inc.
|
Sell |
-21.03% |
3.12% |
2024-04-05 |
ATRI
Atrion Corporation
|
Sell |
3.16% |
0% |
2024-04-12 |
AVNS
Avanos Medical, Inc.
|
Sell |
3.16% |
0% |
2024-04-12 |
BLUE
bluebird bio, Inc.
|
Sell |
3.16% |
0% |
2024-04-12 |
The percentage of cash held in the portfolio is:
35.63%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
VERU |
Sell
All
|
115.66% |
ALPN |
Sell
All
|
65.38% |
Assets Rebalanced
None
2024-04-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VERU
Veru Inc.
|
Buy |
13.16% |
49.4% |
2024-04-04 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
12.55% |
-0.67% |
2024-04-09 |
GKOS
Glaukos Corporation
|
Buy |
12.23% |
-0.91% |
2024-04-09 |
PODD
Insulet Corporation
|
Buy |
12.38% |
4.33% |
2024-04-09 |
SAVA
Cassava Sciences, Inc.
|
Buy |
11.99% |
3.99% |
2024-04-09 |
TDOC
Teladoc Health, Inc.
|
Buy |
11.96% |
-3.72% |
2024-04-10 |
KIDS
OrthoPediatrics Corp.
|
Buy |
12.98% |
4.51% |
2024-04-10 |
MDGL
Madrigal Pharmaceuticals, Inc.
|
Buy |
12.19% |
-1.87% |
2024-04-10 |
ALPN
Alpine Immune Sciences, Inc.
|
Buy |
15.01% |
20.8% |
2024-04-10 |
SMTI
Sanara MedTech Inc.
|
Sell |
-20.83% |
6.25% |
2024-04-03 |
CDXS
Codexis, Inc.
|
Sell |
-23.85% |
2.49% |
2024-04-05 |
The percentage of cash held in the portfolio is:
30.24%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
SLP |
Sell
All
|
0.65% |
Assets Rebalanced
None
2024-04-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VERU
Veru Inc.
|
Buy |
12.8% |
40.96% |
2024-04-04 |
SLP
Simulations Plus, Inc.
|
Buy |
12.8% |
6.71% |
2024-04-05 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
12.8% |
-1.68% |
2024-04-09 |
GKOS
Glaukos Corporation
|
Buy |
12.8% |
0.68% |
2024-04-09 |
PODD
Insulet Corporation
|
Buy |
12.8% |
4.69% |
2024-04-09 |
SAVA
Cassava Sciences, Inc.
|
Buy |
12.8% |
7.76% |
2024-04-09 |
TDOC
Teladoc Health, Inc.
|
Buy |
12.8% |
0% |
2024-04-10 |
KIDS
OrthoPediatrics Corp.
|
Buy |
12.8% |
0% |
2024-04-10 |
MDGL
Madrigal Pharmaceuticals, Inc.
|
Buy |
12.8% |
0% |
2024-04-10 |
ALPN
Alpine Immune Sciences, Inc.
|
Buy |
12.8% |
0% |
2024-04-10 |
SMTI
Sanara MedTech Inc.
|
Sell |
-21.73% |
5.11% |
2024-04-03 |
CDXS
Codexis, Inc.
|
Sell |
-25.36% |
-0.62% |
2024-04-05 |
The percentage of cash held in the portfolio is:
19.09%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
NUTX |
Buy
All
|
-1356.33% |
Assets Rebalanced
Asset |
Action |
Weight |
ORGO |
Sell |
-32.43% |
GKOS |
Sell |
-33.51% |
PODD |
Sell |
-35.36% |
SAVA |
Sell |
-36.77% |
SLP |
Sell |
-38.74% |
VERU |
Sell |
-55.16% |
2024-04-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VERU
Veru Inc.
|
Buy |
15.21% |
24.1% |
2024-04-04 |
SLP
Simulations Plus, Inc.
|
Buy |
12.77% |
3.95% |
2024-04-05 |
GKOS
Glaukos Corporation
|
Buy |
11.7% |
0% |
2024-04-09 |
PODD
Insulet Corporation
|
Buy |
11.7% |
0% |
2024-04-09 |
SAVA
Cassava Sciences, Inc.
|
Buy |
11.7% |
0% |
2024-04-09 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
11.7% |
0% |
2024-04-09 |
SMTI
Sanara MedTech Inc.
|
Sell |
-5.62% |
3.44% |
2024-04-03 |
CDXS
Codexis, Inc.
|
Sell |
-6.41% |
0% |
2024-04-05 |
NUTX
Nutex Health Inc.
|
Sell |
-5.55% |
3.67% |
2024-04-08 |
The percentage of cash held in the portfolio is:
42.82%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
HROW |
Sell
All
|
10.08% |
RGEN |
Buy
All
|
5.86% |
Assets Rebalanced
None
2024-04-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
HROW
Harrow Health, Inc.
|
Buy |
13.9% |
12.58% |
2024-03-26 |
VERU
Veru Inc.
|
Buy |
13.98% |
12.05% |
2024-04-04 |
SLP
Simulations Plus, Inc.
|
Buy |
12.54% |
0.34% |
2024-04-05 |
RGEN
Repligen Corporation
|
Sell |
-6.07% |
5.99% |
2024-03-26 |
SMTI
Sanara MedTech Inc.
|
Sell |
-5.71% |
3.64% |
2024-04-03 |
CDXS
Codexis, Inc.
|
Sell |
-6.48% |
0.62% |
2024-04-05 |
NUTX
Nutex Health Inc.
|
Sell |
-5.87% |
0% |
2024-04-08 |
The percentage of cash held in the portfolio is:
83.71%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CUTR |
Buy
All
|
2.5% |
BGNE |
Buy
All
|
1.31% |
Assets Rebalanced
None
2024-04-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
HROW
Harrow Health, Inc.
|
Buy |
13.74% |
9.58% |
2024-03-26 |
VERU
Veru Inc.
|
Buy |
12.67% |
0% |
2024-04-04 |
SLP
Simulations Plus, Inc.
|
Buy |
12.7% |
0% |
2024-04-05 |
CUTR
Cutera, Inc.
|
Sell |
-5.46% |
9.37% |
2024-03-25 |
BGNE
BeiGene, Ltd.
|
Sell |
-5.93% |
1.61% |
2024-03-25 |
RGEN
Repligen Corporation
|
Sell |
-6.14% |
6.46% |
2024-03-26 |
SMTI
Sanara MedTech Inc.
|
Sell |
-5.85% |
2.9% |
2024-04-03 |
CDXS
Codexis, Inc.
|
Sell |
-6.63% |
0% |
2024-04-05 |
The percentage of cash held in the portfolio is:
90.88%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ATRI |
Buy
All
|
-10.11% |
Assets Rebalanced
None
2024-04-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
HROW
Harrow Health, Inc.
|
Buy |
13.72% |
9.17% |
2024-03-26 |
VERU
Veru Inc.
|
Buy |
12.7% |
0% |
2024-04-04 |
CUTR
Cutera, Inc.
|
Sell |
-5.47% |
9.37% |
2024-03-25 |
BGNE
BeiGene, Ltd.
|
Sell |
-6.04% |
0.05% |
2024-03-25 |
RGEN
Repligen Corporation
|
Sell |
-6.3% |
4.09% |
2024-03-26 |
SMTI
Sanara MedTech Inc.
|
Sell |
-5.97% |
1.08% |
2024-04-03 |
ATRI
Atrion Corporation
|
Sell |
-6.41% |
-6.36% |
2024-04-03 |
The percentage of cash held in the portfolio is:
103.78%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-04-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
HROW
Harrow Health, Inc.
|
Buy |
13.02% |
3.17% |
2024-03-26 |
CUTR
Cutera, Inc.
|
Sell |
-5.42% |
10.63% |
2024-03-25 |
BGNE
BeiGene, Ltd.
|
Sell |
-6.11% |
-0.81% |
2024-03-25 |
RGEN
Repligen Corporation
|
Sell |
-6.35% |
3.76% |
2024-03-26 |
SMTI
Sanara MedTech Inc.
|
Sell |
-6.06% |
0% |
2024-04-03 |
ATRI
Atrion Corporation
|
Sell |
-6.06% |
0% |
2024-04-03 |
The percentage of cash held in the portfolio is:
116.98%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
TNDM |
Sell
All
|
8.77% |
CHRS |
Sell
All
|
-3.67% |
SMMT |
Buy
All
|
-6.06% |
Assets Rebalanced
None
2024-03-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
13.93% |
14.61% |
2024-03-20 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
12% |
-1.22% |
2024-03-20 |
HROW
Harrow Health, Inc.
|
Buy |
13.21% |
6.08% |
2024-03-26 |
SMMT
Summit Therapeutics Inc.
|
Sell |
-5.65% |
-3.31% |
2024-03-20 |
CUTR
Cutera, Inc.
|
Sell |
-5.28% |
11.88% |
2024-03-25 |
BGNE
BeiGene, Ltd.
|
Sell |
-6.11% |
-2.01% |
2024-03-25 |
RGEN
Repligen Corporation
|
Sell |
-6.51% |
0.07% |
2024-03-26 |
The percentage of cash held in the portfolio is:
84.4%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AVXL |
Buy
All
|
-11.21% |
Assets Rebalanced
None
2024-03-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
13.44% |
9.38% |
2024-03-20 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
11.43% |
-6.94% |
2024-03-20 |
HROW
Harrow Health, Inc.
|
Buy |
13.2% |
4.83% |
2024-03-26 |
SMMT
Summit Therapeutics Inc.
|
Sell |
-5.7% |
-3.03% |
2024-03-20 |
CUTR
Cutera, Inc.
|
Sell |
-5.33% |
11.88% |
2024-03-25 |
BGNE
BeiGene, Ltd.
|
Sell |
-6.12% |
-1.18% |
2024-03-25 |
RGEN
Repligen Corporation
|
Sell |
-6.55% |
0.56% |
2024-03-26 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-7.01% |
-6.37% |
2024-03-26 |
The percentage of cash held in the portfolio is:
92.64%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MD |
Sell
All
|
2.46% |
CORT |
Sell
All
|
1.19% |
IBRX |
Sell
All
|
-14.52% |
Assets Rebalanced
None
2024-03-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MD
Pediatrix Medical Group, Inc.
|
Buy |
14.74% |
-0.85% |
2024-03-13 |
CORT
Corcept Therapeutics Incorporated
|
Buy |
14.99% |
0.82% |
2024-03-13 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
12.13% |
-2.27% |
2024-03-20 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
11.55% |
-6.94% |
2024-03-20 |
IBRX
ImmunityBio, Inc.
|
Buy |
10.25% |
-9.18% |
2024-03-21 |
HROW
Harrow Health, Inc.
|
Buy |
12.72% |
0% |
2024-03-26 |
SMMT
Summit Therapeutics Inc.
|
Sell |
-5.05% |
9.64% |
2024-03-20 |
CUTR
Cutera, Inc.
|
Sell |
-5.46% |
10.63% |
2024-03-25 |
BGNE
BeiGene, Ltd.
|
Sell |
-6.19% |
-1.25% |
2024-03-25 |
RGEN
Repligen Corporation
|
Sell |
-6.65% |
0% |
2024-03-26 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-6.65% |
0% |
2024-03-26 |
The percentage of cash held in the portfolio is:
53.63%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
INO |
Sell
All
|
2.99% |
BCRX |
Sell
All
|
-10.24% |
SMTI |
Buy
All
|
0.68% |
MCRB |
Buy
All
|
8.49% |
Assets Rebalanced
None
2024-03-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
INO
Inovio Pharmaceuticals, Inc.
|
Buy |
12.23% |
-3.49% |
2024-03-12 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
14.8% |
-0.43% |
2024-03-13 |
CORT
Corcept Therapeutics Incorporated
|
Buy |
14.88% |
0.16% |
2024-03-13 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
12.18% |
-1.75% |
2024-03-20 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
11.79% |
-4.9% |
2024-03-20 |
IBRX
ImmunityBio, Inc.
|
Buy |
11.43% |
1.34% |
2024-03-21 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
10.33% |
-8.41% |
2024-03-21 |
SMTI
Sanara MedTech Inc.
|
Sell |
-6.73% |
-2.49% |
2024-03-12 |
MCRB
Seres Therapeutics, Inc.
|
Sell |
-5.87% |
10.58% |
2024-03-12 |
SMMT
Summit Therapeutics Inc.
|
Sell |
-5.18% |
7.16% |
2024-03-20 |
CUTR
Cutera, Inc.
|
Sell |
-6.11% |
0% |
2024-03-25 |
BGNE
BeiGene, Ltd.
|
Sell |
-6.11% |
0% |
2024-03-25 |
The percentage of cash held in the portfolio is:
42.37%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ARDX |
Buy
All
|
11.39% |
Assets Rebalanced
None
2024-03-21 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
INO
Inovio Pharmaceuticals, Inc.
|
Buy |
11.28% |
-10.38% |
2024-03-12 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
15.15% |
2.67% |
2024-03-13 |
CORT
Corcept Therapeutics Incorporated
|
Buy |
14.73% |
-0.2% |
2024-03-13 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
12.98% |
5.39% |
2024-03-20 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
12.47% |
1.22% |
2024-03-20 |
IBRX
ImmunityBio, Inc.
|
Buy |
11.2% |
0% |
2024-03-21 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
11.2% |
0% |
2024-03-21 |
ARDX
Ardelyx, Inc.
|
Sell |
-5.73% |
10.24% |
2024-03-11 |
SMTI
Sanara MedTech Inc.
|
Sell |
-6.74% |
-3.26% |
2024-03-12 |
MCRB
Seres Therapeutics, Inc.
|
Sell |
-6.3% |
3.37% |
2024-03-12 |
SMMT
Summit Therapeutics Inc.
|
Sell |
-5.85% |
-5.51% |
2024-03-20 |
The percentage of cash held in the portfolio is:
35.61%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-03-20 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
INO
Inovio Pharmaceuticals, Inc.
|
Buy |
11.25% |
-11.3% |
2024-03-12 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
15.07% |
1.28% |
2024-03-13 |
CORT
Corcept Therapeutics Incorporated
|
Buy |
14.75% |
-0.86% |
2024-03-13 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
12.42% |
0% |
2024-03-20 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
12.42% |
0% |
2024-03-20 |
ARDX
Ardelyx, Inc.
|
Sell |
-5.94% |
7.71% |
2024-03-11 |
SMTI
Sanara MedTech Inc.
|
Sell |
-6.71% |
-2.03% |
2024-03-12 |
MCRB
Seres Therapeutics, Inc.
|
Sell |
-6.16% |
6.28% |
2024-03-12 |
SMMT
Summit Therapeutics Inc.
|
Sell |
-5.59% |
0% |
2024-03-20 |
The percentage of cash held in the portfolio is:
58.49%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
MDXG |
Buy
All
|
-0.63% |
RCKT |
Buy
All
|
2.47% |
Assets Rebalanced
None
2024-03-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
INO
Inovio Pharmaceuticals, Inc.
|
Buy |
11.2% |
-10.96% |
2024-03-12 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
14.84% |
0.53% |
2024-03-13 |
CORT
Corcept Therapeutics Incorporated
|
Buy |
14.67% |
-0.61% |
2024-03-13 |
MDXG
MiMedx Group, Inc.
|
Sell |
-6.38% |
1.5% |
2024-03-06 |
RCKT
Rocket Pharmaceuticals, Inc.
|
Sell |
-6.23% |
3.74% |
2024-03-06 |
ARDX
Ardelyx, Inc.
|
Sell |
-5.76% |
9.78% |
2024-03-11 |
SMTI
Sanara MedTech Inc.
|
Sell |
-6.51% |
0.25% |
2024-03-12 |
MCRB
Seres Therapeutics, Inc.
|
Sell |
-5.75% |
11.86% |
2024-03-12 |
The percentage of cash held in the portfolio is:
89.92%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AVXL |
Sell
All
|
-11.56% |
NSTG |
Sell
All
|
-48.32% |
ABUS |
Sell
All
|
-6.62% |
Assets Rebalanced
None
2024-03-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AVXL
Anavex Life Sciences Corp.
|
Buy |
10.58% |
-4.59% |
2024-03-11 |
INO
Inovio Pharmaceuticals, Inc.
|
Buy |
11.24% |
-4.4% |
2024-03-12 |
NSTG
NanoString Technologies, Inc.
|
Buy |
11.23% |
-4.44% |
2024-03-12 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
11.62% |
-1.1% |
2024-03-12 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
13.79% |
0% |
2024-03-13 |
CORT
Corcept Therapeutics Incorporated
|
Buy |
13.79% |
0% |
2024-03-13 |
MDXG
MiMedx Group, Inc.
|
Sell |
-6.04% |
0.13% |
2024-03-06 |
RCKT
Rocket Pharmaceuticals, Inc.
|
Sell |
-5.94% |
1.78% |
2024-03-06 |
ARDX
Ardelyx, Inc.
|
Sell |
-5.78% |
3.11% |
2024-03-11 |
SMTI
Sanara MedTech Inc.
|
Sell |
-6.15% |
-0.96% |
2024-03-12 |
MCRB
Seres Therapeutics, Inc.
|
Sell |
-5.48% |
10.12% |
2024-03-12 |
The percentage of cash held in the portfolio is:
57.15%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-03-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AVXL
Anavex Life Sciences Corp.
|
Buy |
10.52% |
-4.77% |
2024-03-11 |
INO
Inovio Pharmaceuticals, Inc.
|
Buy |
11.71% |
0% |
2024-03-12 |
NSTG
NanoString Technologies, Inc.
|
Buy |
11.71% |
0% |
2024-03-12 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
11.71% |
0% |
2024-03-12 |
MDXG
MiMedx Group, Inc.
|
Sell |
-6.02% |
0% |
2024-03-06 |
RCKT
Rocket Pharmaceuticals, Inc.
|
Sell |
-6.03% |
-0.18% |
2024-03-06 |
ARDX
Ardelyx, Inc.
|
Sell |
-5.8% |
2.3% |
2024-03-11 |
SMTI
Sanara MedTech Inc.
|
Sell |
-6.07% |
0% |
2024-03-12 |
MCRB
Seres Therapeutics, Inc.
|
Sell |
-6.07% |
0% |
2024-03-12 |
The percentage of cash held in the portfolio is:
84.37%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-03-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AVXL
Anavex Life Sciences Corp.
|
Buy |
11.02% |
0% |
2024-03-11 |
MDXG
MiMedx Group, Inc.
|
Sell |
-6.13% |
-2% |
2024-03-06 |
RCKT
Rocket Pharmaceuticals, Inc.
|
Sell |
-6.08% |
-1.16% |
2024-03-06 |
ARDX
Ardelyx, Inc.
|
Sell |
-5.93% |
0% |
2024-03-11 |
The percentage of cash held in the portfolio is:
107.12%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-03-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MDXG
MiMedx Group, Inc.
|
Sell |
-6% |
0% |
2024-03-06 |
RCKT
Rocket Pharmaceuticals, Inc.
|
Sell |
-6% |
0% |
2024-03-06 |
The percentage of cash held in the portfolio is:
112%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-02-13 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CBAY |
Sell
All
|
35.68% |
Assets Rebalanced
None